期刊文献+

萘哌地尔的药理学研究和临床应用 被引量:23

The pharmacology and clinical uses of naftopidil
下载PDF
导出
摘要 萘哌地尔是一种新型的选择性α1 受体阻断剂 ,其α1 受体阻断作用具有组织选择性和受体亚型的选择性 ,并且可阻断钙通道、兴奋 5 HT1A受体。在临床上主要用于治疗高血压病和良性前列腺增生。本文就萘哌地尔的药代动力学、药效学。 Naftopidil is a new type of selective α 1 adrenoceptor antagonist.It possesses the selectivity of tissue and subtype α 1 adrenoceptor,exhibits calcium channel blocking effect and excits 5 HT 1A receptor.In clinical setting,it is mainly used to treat essential hypertension and benign prostate hyperplasia.In this paper,the pharmacodynamics,pharmacokinetics,initial clinical trials,and safety of naftopidil were reviewed.
出处 《中国新药杂志》 CAS CSCD 北大核心 2001年第8期579-582,共4页 Chinese Journal of New Drugs
关键词 萘哌地尔 药代动力学 药效学 临床试验 药理 naftopidil pharmacokinetics pharmacodynamics clinical trial
  • 相关文献

参考文献20

  • 1[1]Peter G,Niebch G,Locher M,et al.Pharmacokinetic fate of the novel antihypertensive drug naftopidil[J].Arzneimittelforschun g,1991,41(9)∶924-93 1.
  • 2[2]Niebch G,Locher M,Borbe HO.Metabolic fate of the novel antihypert ensive drug naftopidil[J].Arzneimittelforschung,1991,41(10)∶1027-1032.
  • 3[3]Borbe HO,Peter G.Radioreceptor assay for the determination of alp ha1-adr enoceptor-binding material in rat plasma following single oral administration o f naftopidil[J].Arzneimittelforschung,1990,40(3)∶253-256.
  • 4[4]Niebch G, Borbe HO,Besenfelder E.High-performance liquid chromat ography of naftopidil,a novel antihypertensive drug, and two metabolites in human plasm a[J].J Chromatogr,1990,534∶247-252.
  • 5[5]Terakado T,Oki E,Iida M,et al.Metabolism of naftopidil (KT-6 11) in healthy volunteers[J].J Clin Ther Med,1992,8(Suppl 3)∶S3-S9.
  • 6[6]NN.Naftopidil:Investigational Drug Brochure[R].ASTA Medica AG,1 992.
  • 7[7]Takagi N,Ishii M,Takeda K,et al.Pharmacokinetics of naftopidi l (KT-6 11) in hypertensive patients with renal impairment or normal renal function[J] .J Clin Ther Med,1992,8(Suppl 3)∶S109-S122.
  • 8[8]Farthing MJ,Alstead EM,Abrams SM,et al.Pharmacokinetics of na ftopidil ,a novel anti-hypertensive drug,in patients with hepatic dysfunction[J].Pos tgrad Med J,1994,70(823)∶363-366.
  • 9[9]Sponer G,Borbe HO,Muller-Beckmann B,et al.Naftopidil,a new a drenocep tor blocking agent with Ca(2+)-antagonistic properties:interaction with adrenoc eptors[J].J Cardiovasc Pharmacol,1992,20(6)∶1006-1013.
  • 10[10]Muramatsu I,Yamanaka K,Kigoshi S.Pharmacological profile of the novel al pha-adrenoceptor antagonist KT-611 (naftopidil)[J].Jpn J Pharmacol,1991, 55(3)∶391-398.

同被引文献128

引证文献23

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部